BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31095609)

  • 1. Hypoalbuminemia is a frequent marker of increased mortality in cardiogenic shock.
    Jäntti T; Tarvasmäki T; Harjola VP; Parissis J; Pulkki K; Javanainen T; Tolppanen H; Jurkko R; Hongisto M; Kataja A; Sionis A; Silva-Cardoso J; Banaszewski M; Spinar J; Mebazaa A; Lassus J;
    PLoS One; 2019; 14(5):e0217006. PubMed ID: 31095609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial.
    Fuernau G; Pöss J; Denks D; Desch S; Heine GH; Eitel I; Seiler S; de Waha S; Ewen S; Link A; Schuler G; Adams V; Böhm M; Thiele H
    Crit Care; 2014 Dec; 18(6):713. PubMed ID: 25528363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Measurement of Soluble ST2 and Amino-Terminal Pro-B-Type Natriuretic Peptide Provides Early Assessment of Severity in Cardiogenic Shock Complicating Acute Coronary Syndrome.
    Tolppanen H; Rivas-Lasarte M; Lassus J; Sadoune M; Gayat E; Pulkki K; Arrigo M; Krastinova E; Sionis A; Parissis J; Spinar J; Januzzi J; Harjola VP; Mebazaa A;
    Crit Care Med; 2017 Jul; 45(7):e666-e673. PubMed ID: 28403119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome.
    Prondzinsky R; Lemm H; Swyter M; Wegener N; Unverzagt S; Carter JM; Russ M; Schlitt A; Buerke U; Christoph A; Schmidt H; Winkler M; Thiery J; Werdan K; Buerke M
    Crit Care Med; 2010 Jan; 38(1):152-60. PubMed ID: 19770739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating levels of microRNA 423-5p are associated with 90 day mortality in cardiogenic shock.
    Jäntti T; Segersvärd H; Tolppanen H; Tarvasmäki T; Lassus J; Devaux Y; Vausort M; Pulkki K; Sionis A; Bayes-Genis A; Tikkanen I; Lakkisto P; Harjola VP
    ESC Heart Fail; 2019 Feb; 6(1):98-102. PubMed ID: 30472788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline serum bicarbonate levels independently predict short-term mortality in critically ill patients with ischaemic cardiogenic shock.
    Wigger O; Bloechlinger S; Berger D; Häner J; Zanchin T; Windecker S; Räber L; Schefold JC
    Eur Heart J Acute Cardiovasc Care; 2018 Feb; 7(1):45-52. PubMed ID: 28838261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of mortality in patients with cardiogenic shock treated with primary percutaneous coronary intervention and intra-aortic balloon counterpulsation.
    Schwarz B; Abdel-Wahab M; Robinson DR; Richardt G
    Med Klin Intensivmed Notfmed; 2016 Nov; 111(8):715-722. PubMed ID: 26596273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative hypoalbuminemia is associated with poor clinical outcomes after open and endovascular abdominal aortic aneurysm repair.
    Inagaki E; Farber A; Eslami MH; Kalish J; Rybin DV; Doros G; Peacock MR; Siracuse JJ
    J Vasc Surg; 2017 Jul; 66(1):53-63.e1. PubMed ID: 28216349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoalbuminemia Predicts Perioperative Morbidity and Mortality after Infrainguinal Lower Extremity Bypass for Critical Limb Ischemia.
    Peacock MR; Farber A; Eslami MH; Kalish JA; Rybin D; Doros G; Shah NK; Siracuse JJ
    Ann Vasc Surg; 2017 May; 41():169-175.e4. PubMed ID: 28242402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered mental status predicts mortality in cardiogenic shock - results from the CardShock study.
    Kataja A; Tarvasmäki T; Lassus J; Køber L; Sionis A; Spinar J; Parissis J; Carubelli V; Cardoso J; Banaszewski M; Marino R; Nieminen MS; Mebazaa A; Harjola VP
    Eur Heart J Acute Cardiovasc Care; 2018 Feb; 7(1):38-44. PubMed ID: 28403620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of Growth Differentiation Factor 15 and Early Mortality Risk Stratification in Cardiogenic Shock.
    Hongisto M; Kataja A; Tarvasmäki T; Holopainen A; Javanainen T; Jurkko R; Jäntti T; Kimmoun A; Levy B; Mebazaa A; Pulkki K; Sionis A; Tolppanen H; Wollert KC; Harjola VP; Lassus J;
    J Card Fail; 2019 Nov; 25(11):894-901. PubMed ID: 31310811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical picture and risk prediction of short-term mortality in cardiogenic shock.
    Harjola VP; Lassus J; Sionis A; Køber L; Tarvasmäki T; Spinar J; Parissis J; Banaszewski M; Silva-Cardoso J; Carubelli V; Di Somma S; Tolppanen H; Zeymer U; Thiele H; Nieminen MS; Mebazaa A; ;
    Eur J Heart Fail; 2015 May; 17(5):501-9. PubMed ID: 25820680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality after emergent percutaneous coronary intervention in cardiogenic shock secondary to acute myocardial infarction and usefulness of a mortality prediction model.
    Klein LW; Shaw RE; Krone RJ; Brindis RG; Anderson HV; Block PC; McKay CR; Hewitt K; Weintraub WS;
    Am J Cardiol; 2005 Jul; 96(1):35-41. PubMed ID: 15979429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Albumin Is an Independent Predictor of Clinical Outcomes in Critically Ill Children.
    Leite HP; Rodrigues da Silva AV; de Oliveira Iglesias SB; Koch Nogueira PC
    Pediatr Crit Care Med; 2016 Feb; 17(2):e50-7. PubMed ID: 26695729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple risk chart for initial risk assessment of 30-day mortality in patients with cardiogenic shock from ST-elevation myocardial infarction.
    Cheng JM; Helming AM; van Vark LC; Kardys I; Den Uil CA; Jewbali LS; van Geuns RJ; Zijlstra F; van Domburg RT; Boersma E; Akkerhuis KM
    Eur Heart J Acute Cardiovasc Care; 2016 Apr; 5(2):101-7. PubMed ID: 25589634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiopoietin-2 in acute myocardial infarction complicated by cardiogenic shock--a biomarker substudy of the IABP-SHOCK II-Trial.
    Pöss J; Fuernau G; Denks D; Desch S; Eitel I; de Waha S; Link A; Schuler G; Adams V; Böhm M; Thiele H
    Eur J Heart Fail; 2015 Nov; 17(11):1152-60. PubMed ID: 26333723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of miR-21-5p, miR-122-5p, and miR-320a-3p with 90-Day Mortality in Cardiogenic Shock.
    Hänninen M; Jäntti T; Tolppanen H; Segersvärd H; Tarvasmäki T; Lassus J; Vausort M; Devaux Y; Sionis A; Tikkanen I; Harjola VP; Lakkisto P; For The CardShock Study Group
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catalytic iron in acute myocardial infarction complicated by cardiogenic shock - A biomarker substudy of the IABP-SHOCK II-trial.
    Fuernau G; Traeder F; Lele SS; Rajapurkar MM; Mukhopadhyay B; de Waha S; Desch S; Eitel I; Schuler G; Adams V; Thiele H
    Int J Cardiol; 2017 Jan; 227():83-88. PubMed ID: 27865117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Obesity With In-Hospital Mortality of Cardiogenic Shock Complicating Acute Myocardial Infarction.
    Chatterjee K; Gupta T; Goyal A; Kolte D; Khera S; Shanbhag A; Patel K; Villablanca P; Agarwal N; Aronow WS; Menegus MA; Fonarow GC; Bhatt DL; Garcia MJ; Meena NK
    Am J Cardiol; 2017 May; 119(10):1548-1554. PubMed ID: 28363355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Albumin Predicts Survival and Postoperative Course Following Surgery for Geriatric Hip Fracture.
    Bohl DD; Shen MR; Hannon CP; Fillingham YA; Darrith B; Della Valle CJ
    J Bone Joint Surg Am; 2017 Dec; 99(24):2110-2118. PubMed ID: 29257017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.